About

About Keiji AI Keiji AI is transforming oncology clinical research with TrialMind, an AI-native platform supporting biostatistics, clinical operations, and trial design end to end. Built on foundation models trained on millions of trial protocols, publications, and real-world oncology datasets, TrialMind enables teams to optimize eligibility criteria, run feasibility and enrollment forecasting, generate and validate statistical analyses, simulate trial outcomes with digital twins, and draft regulatory-ready documents. Trusted by leading pharma and biotech organizations, Keiji AI helps oncology trials execute faster, with higher quality, and greater confidence across design, operations, and analysis.